$DSS Income Statement | Understand Stock

$DSS

$0.50 -$0.01 (1.2%) Close

$DSS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Printed Products
Rental Revenue Income
Management Revenue Fee Income
Net Investment Revenue Income
Rental Income
Management Fee Income
Net Investment Income
Direct Marketing
Commission Revenue
Commercial Lending
Commission
Biotechnology
Total revenue

Costs and expenses:
Cost of revenue
Selling, general and administrative (including stock-based compensation)
Depreciation and amortization
Total costs and expenses
Operating loss
Other income (expense):
Interest income
Interest income on note receivable, related party
Dividend income
Other
Interest expense
Litigation loss
Foreign Currency Translation Adjustment
Gain on extinguishment of debt
(Loss)/gain on equity method investment
(Loss) gain on investments
Impairment of fixed asset
Impairment of fixed assets
Impairment of investment
Impairment of assets upon deconsolidation of SHRG
Impairment of goodwill
Impairment of real estate assets
Provision for loan losses
Loss on sale of assets

Loss from operations before income taxes
Income tax benefit
Loss from continuing operations
Loss from discontinued operations, net of tax
Net loss
Loss from operations attributed to noncontrolling interest
Net loss attributable to DSS common stockholders
Loss from continuing operations net of taxes
Loss from discontinued operations net of taxes
Basic
Diluted
Loss per common share attributable to common stockholders
Basic
Diluted
Shares used in computing loss per common share:
Basic
Diluted

Comments